Amaris offers multiple services to biotechnology companies and pharmaceutical labs, from support for product development to the design of internal procedures. Our teams’ objective is to optimise procedures, improve productivity, ensure quality and reduce costs.
We bring technical solutions to all levels of the value chain: from clinical research to administrative and commercial management of projects as part of research and development of new technologies in the health-care sector.
Our HEMA department focuses its activity on medical and economic assessment. These studies are used in negotiating prices, reimbursement issues and market access strategies.
The problem areas studied cover epidemiology, measuring the impact of a pathology, clinical and economic evaluation. We operate through a structured portfolio of projects including publications, value dossiers, market access toolkits and tenders in new health-care technologies.